
ABOUT ACTIGRAPH
ActiGraph is pioneering the digital transformation of clinical research. We provide end-to-end digital health technology (DHT) solutions by integrating and operationalizing the best hardware, software, and algorithms to generate reliable evidence and get the right treatments to the right patients, faster. ActiGraph’s medical-grade wearable technology platform has been used to capture real-world, continuous digital measures for nearly 200 industry-sponsored clinical trials and thousands of academic research studies. Appearing in over 20,000 published scientific papers to date, ActiGraph is the most experienced and trusted wearable technology partner in the industry.
DIGITAL ENDPOINTS LIBRARY
-
Explore how sensor-based digital health technologies can revolutionize the treatment and management of movement disorders by providing more accurate, patient-centered outcomes.
-
Find out how sensor-based digital health technologies (DHTs) offer direct, objective daily life assessments, accelerating NMD drug development.
-
Explore how digital health technologies can enhance obesity treatment by providing critical insights beyond weight loss.
-
Discover how recent advancements in wearable sensors and data science have provided the opportunities for objective and unobtrusive assessment of walking in the real world.
-
People with cancer emphasize quality of life (QOL) as an important health outcome across their journey. Explore how digital health technologies can collect patient-centric outcomes passively and remotely, minimizing the burden for people to participate in clinical trials.
-
Explore how an objective scratch measure is now achievable through the use of wrist-worn wearable technology that is both non-invasive and easy to implement.
-
Drug development in neurology is notoriously challenging. Despite being one of the most active areas of clinical development, neurological disease drug trials have among the longest development timelines and highest failure rates in the industry. Learn more in the available e-Book.
-
Wearable devices provide a low-burden and remote approach to quantifying people’s sleep. While difficult to estimate, learn how actigraphy is sensitive to treatment effects.
CONTACT INFORMATION
ActiGraph
70 N Baylen St, Suite 400
Pensacola, FL 32502
UNITED STATES
Phone: 850.332.7900
Contact: Genevieve Baley
SOLUTIONS
- A New Digital Health Solution For Continuous, Long-Term Cough Monitoring
- Modernizing Clinical Research Through Digital Transformation
- Wearable Device Comparison Guide: Medical-Grade Or Consumer Device?
- Accelerate Clinical Development With Patient-Centered Digital Measures
- LEAP: A Multisensor Wearable For Patient-Centered Clinical Research
- CentrePoint: The Robust Digital Health Technology Platform
FEATURED ARTICLES
- Digital Outcome Measures Approved As Primary Endpoint In Cardiopulmonary Study
- Accelerate Respiratory Disease Trials: A Guide To Digital Endpoints
- A Guide To Digital Endpoints In Major Depressive Disorder
- Wearable DHT 10: Foundations, Regulations, And Real-World Applications
- Digital Health Solution For CRS Detection And Prediction
- Cytokine Release Syndrome Monitoring
- Different Stakeholder Perspectives On Navigating DHT Guidance
- Measuring Critical Health Outcomes Beyond Weight Loss In GLP-1 And Related Obesity Treatments
- Treatment Benefits Of Wearable DHTs For Patients With Cancer Cachexia
- Parkinson's Disease: Leveraging Wearable DHTs
- Real-World Value Realized From DHTs In Clinical Trials
- Demystifying AI: The Fundamentals And Applications In Drug Development
- Digital Endpoint Resource Guide: Parkinson's Disease
- Digital Measures To Advance Research And Quality Of Life In Schizophrenia
- Digital Endpoint Resource Guide: Obesity And Related Metabolic Disorders
- Wearable DHT 101: Foundations For Use In Regulated Clinical Trials
- Improving Patient Outcomes With Wearables In Major Depressive Disorder
- Database To Advance Patient-Focused Drug Development With DHTs
- Enhancing Activity And Gait Monitoring In Children Using DHTs
- Looking Beyond Weight Loss In The Obesity Pandemic: What's Next?